CD138-directed adoptive immunotherapy of chimeric antigen receptor (CAR)-modified T cells for multiple myeloma
Under a Creative Commons license
open access
Keywords
Chimeric antigen receptor-modified T cells
Multiple myeloma
CD138
Cited by (0)
Peer review under responsibility of Shanghai Hengrun Biomedical Technology Research Institute.
- 1
The authors Dr. Bo Guo, Dr. Meixia Chen, Dr. Qingwang Han contributed equally to this work.